SEC Info - Nymox Pharmaceutical Corp - ‘20-F’ for 12/31/04

SEC Info℠

Home

Help

Please Sign In

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/04

On: Thursday, 6/30/05, at 12:45pm ET · For: 12/31/04 · Accession #: 897069-5-1630 · File #: 1-12033

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/30/05  Nymox Pharmaceutical Corp         20-F       12/31/04    5:988K                                   Foley & Lardner/FA

Annual Report of a Foreign Private Issuer — Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report                                       HTML    945K 
 2: EX-12.(A)   Statement re: Computation of Ratios                 HTML     11K 
 3: EX-12.(B)   Statement re: Computation of Ratios                 HTML     11K 
 4: EX-13.(A)   Annual or Quarterly Report to Security Holders      HTML      6K 
 5: EX-13.(B)   Annual or Quarterly Report to Security Holders      HTML      6K

Filing Submission 0000897069-05-001630 – SGML Text

Original SGML Text submitted by:	Foley & Lardner/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/04

On: Thursday, 6/30/05, at 12:45pm ET · For: 12/31/04 · Accession #: 897069-5-1630 · File #: 1-12033

Previous ‘20-F’: ‘20-F’ on 6/30/04 for 12/31/03 · Next: ‘20-F/A’ on 10/24/05 for 12/31/04 · Latest: ‘20-F’ on 5/2/23 for 12/31/22 · 2 References: By: SEC – ‘UPLOAD’ on 10/27/05 By: SEC – ‘UPLOAD’ on 8/25/05

Annual Report of a Foreign Private Issuer — Form 20-FFiling Table of Contents

To view the SGML, please refresh this page.

Previous ‘20-F’: ‘20-F’ on 6/30/04 for 12/31/03 · Next: ‘20-F/A’ on 10/24/05 for 12/31/04 · Latest: ‘20-F’ on 5/2/23 for 12/31/22 · 2 References:

Annual Report of a Foreign Private Issuer — Form 20-F
Filing Table of Contents

To view the SGML, please refresh
this page.